MediPharm Labs (STU:MLZ) 5-Year EBITDA Growth Rate : 0.00% (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is MediPharm Labs 5-Year EBITDA Growth Rate?

MediPharm Labs's EBITDA per Share for the three months ended in Mar. 2024 was €-0.01.

During the past 3 years, the average EBITDA Per Share Growth Rate was 57.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 7 years, the highest 3-Year average EBITDA Per Share Growth Rate of MediPharm Labs was 57.80% per year. The lowest was 22.50% per year. And the median was 40.15% per year.

Competitive Comparison of MediPharm Labs's 5-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, MediPharm Labs's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MediPharm Labs's 5-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MediPharm Labs's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where MediPharm Labs's 5-Year EBITDA Growth Rate falls into.

MediPharm Labs 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

MediPharm Labs (STU:MLZ) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

MediPharm Labs 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of MediPharm Labs's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

MediPharm Labs (STU:MLZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (STU:MLZ) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

MEDIF:USA MLZ:Germany LABS:Canada

Address

151 John Street, Barrie, ON, CAN, L4N 2L1

Website

https://www.medipharmlabs.com

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis extracts and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.

MediPharm Labs (STU:MLZ) Headlines

No Headlines